Atlanta – September 29, 2026 -- Patients considering peptide treatments now have a clear checklist for confirming whether the person prescribing their medication is actually licensed, according to a new HelloNation article featuring insights from Wellness Expert Andres Giraldo.
The article argues that legitimate peptide care should make it easy to identify who is responsible for a patient's treatment. A first name, a title, or a vague reference to a "care team" is not sufficient to confirm who is actually making prescribing decisions.
State license lookup tools confirm a clinician's active status.
Most states maintain a public license lookup through their medical or nursing board. Searching a clinician's name there shows whether the license is active, in good standing, and free of public disciplinary action, ruling out expired licenses as well as those under investigation, suspended, or restricted.
The National Provider Identifier registry offers a free federal check.
This database confirms whether someone is registered as a legitimate healthcare provider, giving patients a second point of verification beyond state records.
A prescriber must be licensed in the state where the patient is located.
The article notes that clinicians generally need state-specific licensing tied to the patient's physical location, and a legitimate provider should confirm that alignment without hesitation. Patients should also expect a real point of contact for the specific clinician handling their care, rather than a shared inbox.
Pharmacy verification follows the same logic as prescriber checks.
State boards of pharmacy maintain license lookup tools, and a legitimate pharmacy should appear there under a name matching the patient's paperwork. A physical address matters too; a company offering only a P.O. box deserves closer scrutiny, according to the article.
Large telehealth platforms often work through a medical group contracting with multiple clinicians, which the article describes as common and not inherently problematic, provided each case is traceable to one named, licensed person. Dispensing labels should list the pharmacy's name, address, and license number so a specific product can be matched to its testing documentation.
Giraldo's insights point to a simple test: asking directly for a prescriber's name and license number, a process the article says typically takes no more than fifteen or twenty minutes. If a company cannot produce a specific prescriber name, the article treats that as a significant warning sign.